Kura Oncology announces pricing of $100 million public offering of common stock
Kura Oncology announced pricing of an underwritten public offering of 5,900,000 shares of its common stock at a price to the public of $17.00 per share. Kura granted underwriters a 30-day option to purchase up to an additional 885,000 shares of its common stock. June 19, 2019